Innate and adaptive immunity are equally important for the anti-tumor response and immunotherapy simultaneously activating both arms could have therapeutic benefits. Here authors show that a composite nanoparticle platform that immobilizes monoclonal antibodies targeting PD-L1, 4- 1BB and NKG2A or TIGIT recruits and activates both NK and CD8 + T cells.
- Qian-Ni Ye
- Long Zhu
- Jun Wang
